MedeAnalytics, the healthcare analytics company in California has appointed Paul Kaiser as their new Chief Executive Officer or the CEO. He succeeds Andrew Hurd, who served was the CEO of MedeAnalytics for more than four years.
Paul Kaiser the new CEO of MedeAnalytics
Kaiser holds an experience in the healthcare industry for more than a decade. Before this healthcare analytics provider company, Paul Kaiser served as the President of TriZetto Provider Solutions. He was also appointed as the Director of Sales at Cerner Corporation’s managed services portfolio. During his tenure in Cerner, Paul had led the launch of company’s global managed services solution. Kaiser believes in creating a culture of integrity and trust through transparency and accountability that leads to a productive, engaged workforce and more impactful customer outcomes.
Kaiser mentions about his new association,
“I am honored to join the team at MedeAnalytics. An understanding of cost, quality, and operational insight is paramount during this transitional time in healthcare. MedeAnalytics’ sole focus has been and will continue to be to strengthen the business of healthcare in order to improve care. I look forward to working with our clients and teams to forward our mission.”
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
On his appointment in the company as the CEO, David Weiss mentions why Paul Kaiser’s association with the company will benefit the company. David Weiss is the chairman of this healthcare analytics provider company’s board of directors. He says,
“Paul’s impressive knowledge of the healthcare marketplace and deep understanding of the problems our clients are trying to solve uniquely positions him to lead MedeAnalytics.”
Andrew Hurd’s tenure with MedeAnalytics
Paul Kaiser replaced Andrew Hurd this year. When Hurd served as the CEO, the company saw steady and impressive growth in annual bookings. Now the company also provides solutions to over 1,500 health plans and providers. During his tenure, MedeAnalytics also acquired Thoma Bravo in 2015. This acquisition helped the healthcare analytics provider company leverage the private equity firm’s resources as a strategic partner to accelerate the company’s growth.
Date: June 27, 2017